A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...

Nutritional and health experts say that having it to start the day has major benefits including blood sugar levels, ...

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

Eli Lilly LLY announced that its investigational oral, once-daily cholesterol-lowering drug muvalaplin reduced lipoprotein(a) ...

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

In a study by the Northwestern Medicine Canning Thoracic Institute in Chicago, the RNA in the SARS-CoV-2 virus was found to "trigger the development of a unique type of immune cell with anti-cancer ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Each year, over half a million Americans have a stroke, but up to 80% may be preventable with better nutrition, exercise and ...

Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...

A troubled Orleans County nursing home – already in the crosshairs of the state attorney general – is facing more than ...

Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where ...